Table 5.

Ongoing Clinical Trials Investigating Novel Combination Treatment Regimens for Both RCC and HCC

Trial Name	Phase	Target Population	Treatment Arms	Primary Endpoint	Secondary Endpoint	Estimated Study Completion Date
NCT03170960	Ib	Locally advanced, metastatic, or recurrent solid tumor	Cabozantinib + Atezolizumab	MTD, ORR	Incidence and severity of AE	December 2020